After Selling Their First Spin-out to Medtronic, this Team is Aiming for an Even Bigger Splash in the Wearables Space

Interview with Darrel Drinan

When most people think of the wearables space, devices like the Fitbit or the Apple Watch come to mind. But over the past few years, there’s been a lot of development with respect to wearable devices that were designed for the traditional healthcare market.

Medtronic launched the SEEQ device. Although implantable, St. Jude commercialized the CardioMEMS device. And startups like AliveCor and AUM Cardiovascular have developed some innovative monitoring devices as well.

But there’s some major differences between consumer wearables (like the Fitbit) and wearable devices that are designed for remote monitoring within the traditional healthcare setting. In order to get a better picture of this market, I recently interviewed Darrel Drinan, one of the prominent thought leaders within the wearables (remote monitoring) arena.

In this interview with Darrel, we cover his broad experience developing novel monitoring devices and what he’s learned along the way through deals with DARPA, Medtronic, and his new startup, BioRibbon Health.

Interview Highlights with Darrel Drinan

  • How Corventis was born based on initial funding by DARPA for the design of wearable patches for military applications.

  • Darrel’s opinions on whether the popularity in the wearables space is justified. And the differences between the consumer wearables market vs. the healthcare wearables market.

  • How Darrel and his team are approaching an under-served part of the wearables market through technology they’re developing at BioRibbon Health.

  • What happens when R&D teams “drink their own KOOL-AID”.

  • Darrel’s “rule of 3” for designing consumer-based healthcare products.

  • The lessons Darrel learned at Corventis and how he’s applying them to his new startup, BioRibbon Health.

  • Darrel’s favorite business book, the business leader that most inspires him, and the advice he’d give to his 30-yr. old self.

Premium Members Only

Premium Members Only

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You May Like These Articles

Medsider Premium

Become a premium member and unlock access to exclusive Medsider benefits.

Medsider Mentors

Medsider Mentors

Medsider Playbooks

Medsider Playbooks

Playbook

A Guide to Widespread Adoption in Medtech

In medtech, developing novel, impactful technology is often just the starting line. The real race begins when you try to integrate your solution into the often-resistant healthcare system – a hurdle that has tripped up countless promising companies. Here are the key strategies and lessons from five veterans in the medtech space on how to overcome this hurdle.

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest